Citations

Showing 10 of 108152 citations.

Implementation strategies for interventions to improve the management of chronic kidney disease (CKD) by primary care clinicians: protocol for a systematic review
Kamath, Celia , Dobler, Claudia C. , Erwin, Patricia J., Matulis, John C. , Elrashidi, Muhamad Y. , McCoy, Rozalina G. , Alsawaz, Mouaz, Pajouhi, Atieh, Vasdev, Amrit K., Shah, Nilay D., Murad, M. Hassan , Kamath, Celia C , Lampman, Michelle A. , Matulis, John, Elrashidi, Muhamad, McCoy, Rozalina Grubina , Vasdev, Amrit, Thorsteinsdottir, Bjorg , Murad, M Hassan

Mayo Clinic

BMJ Open | August 9, 2019 | Volume: 9 | Issue: 8 | Pages: e027206

10.1136/bmjopen-2018-027206 | PMID 31399451 Get It

Introduction There is a considerable implementation gap in managing early stage chronic kidney disease (CKD) in primary care despite the high prevalence and risk for increased morbidity and mortality associated with CKD. This systematic review aims to synthesise the evidence of efficacy of implementation interventions aimed at primary care practitioners (PCPs) to improve CKD identification and management. We further aim to describe the interventions’ behavioural change components. Methods and analysis We will conduct a systematic review of studies from 2000 to October 2017 that evaluate implementation interventions targeting PCPs and which include at least one clinically meaningful CKD outcome. We will search several electronic data bases and conduct reference mining of related systematic reviews and publications. An interdisciplinary team will independently and in duplicate, screen publications, extract data and assess the risk of bias. Clinical outcomes will include all clinically meaningful medical management outcomes relevant to CKD management in primary care such as blood pressure, chronic heart disease and diabetes target achievements. Quantitative evidence synthesis will be performed, where possible. Planned subgroup analyses include by (1) study design, (2) length of follow-up, (3) type of intervention, (4) type of implementation strategy, (5) whether a behavioural or implementation theory was used to guide study, (6) baseline CKD severity, (7) patient minority status, (8) study location and (9) academic setting or not. Ethics and dissemination Approval by research ethics board is not required since the review will only include published and publicly accessible data. Review findings will inform a future trial of an intervention to promote uptake of CKD diagnosis and treatment guidelines in our primary care setting and the development of complementary tools to support its successful adoption and implementation. We will publish our findings in a peer-reviewed journal and develop accessible summaries of the results. PROSPERO registration number CRD42018102441.
Peri-Myocardial Infarction Pericarditis: Current Concepts
Michael, Gharacholou S, Bryan, Vaca-Cartagena F, Pragnesh, Parikh P, Peter, Pollak M, Charles, Bruce, Vaca‐Cartagena, Bryan F. , Bryan, Vaca-Cartagena F

Mayo Clinic

Clinical Cardiology and Cardiovascular Medicine | August 9, 2019 | Volume: No volume available | Issue: No issue available | Pages: 23-26

10.33805/2639.6807.121 Get It

Peri-Myocardial Infarction Pericarditis (PMIP), or epistenocardiac pericarditis, has been considered a relatively benign condition occurring within a few days after Myocardial Infarction (MI). Although the condition usually does not require specific treatment, the finding of a pericardial friction rub in the post-MI patient does prompt a careful review of post-MI symptoms and test results, including dysrhythmia recordings, Electro-Cardio Grams (EKG), and the Transthoracic Echocardiogram (TTE) to exclude potentially life threatening post-MI mechanical complications such as free wall rupture. The auscultatory findings of a pericardial rub often represent a teaching opportunity for house staff and students, yet given the self-limited course of PMIP, very little is known regarding the mechanism, biology, imaging findings, and management strategy in patients with and without symptoms. We review the current understanding of PMIP for clinicians caring for post-MI patients.
‘RED’ groups: a bottom‐up approach to wellness
Nordhues, Hannah C. , Kashiwagi, Deanne T. , Kubey, Alan , Kubey, Alan A , Haddox, Candace L.

Mayo Clinic

The Clinical Teacher | August 8, 2019 | Volume: 16 | Issue: 4 | Pages: 420-422

10.1111/tct.13076 | PMID 31397100 Get It

Recruiting the Next Generation of Surgeon-Scientists in Plastic and Reconstructive Surgery: The Value of Research Fellowships
DeCoster, Ryan , Rinker, Brian, Vásconez, Henry C., Rinker, Brian D

Mayo Clinic

Plastic & Reconstructive Surgery | August 8, 2019 | Volume: 144 | Issue: 5 | Pages: 944e-945e

10.1097/prs.0000000000006136 | PMID 31403567 Get It

Integration of high velocity test object motion into a channelized Hotelling observer for the assessment of x-ray angiography systems
Tao, Ashley , Fetterly, Kenneth A. , Fetterly, Kenneth

Mayo Clinic

Physics in Medicine & Biology | August 8, 2019 | Volume: 64 | Issue: 18 | Pages: 185011

10.1088/1361-6560/ab39c4 | PMID 31394507 Get It

Abstract Assessment of x-ray angiography system performance is typically performed using stationary test objects with simple geometries such as a disk on a uniform background. However, these methods do not represent realistic imaging conditions in interventional cardiology as anatomy and devices are inherently non-stationary due to cardiac motion. In this work, a novel implementation of the channelized Hotelling observer (CHO) was used to assess the influence of motion blur on object detectability. A standard CHO model assumes imaging system stationarity whereby the detectability index of a test object is independent of location. However, real angiography systems are inherently non-stationary. While vendor correction gain factors and offset maps are used to compensate for visual non-uniformities, these corrections do not restore stationarity to the images. Methods to accommodate non-stationarity and allow assessment of the influence of motion blur on test object detectability will be presented. The effect of motion blur was quantified with the relative detectability index ( ), where the for an object when moving with constant linear velocity was compared to a low velocity ‘pseudo-stationary’ condition to account for system non-stationarity. The pseudo-stationary condition was used to isolate the influences of spatial non-stationarity and motion blur. Three different test object shapes (disks, spheres and capsules) with linear velocity in the range 0–30 cm · s −1 were tested. For 1 mm diameter objects and linear velocity 30 cm · s −1 , was degraded by 37%, 33% and 42% for the disk, sphere and capsule respectively, relative to the pseudo-stationary condition. Considering all test objects with diameter greater than 2 mm and linear velocity 30 cm · s −1 , was degraded by less than 10% due to motion. In summary, this work describes a new approach to assess performance of x-ray angiography systems using the CHO model and moving test objects.
Outcome of endoscopic resection of colonic polyps larger than 10 mm in patients with inflammatory bowel disease
Yadav, Siddhant, Harmsen, William S. , Song, Louis M. Wong Kee , Wong Kee Song, Louis M, Loftus, Edward V. , Coelho–Prabhu, Nayantara

Mayo Clinic

Endoscopy International Open | August 8, 2019 | Volume: 07 | Issue: 08 | Pages: E994-E1001

10.1055/a-0953-2021 | PMID 31404424 Get It

Abstract Background and study aims There are limited published data on endoscopic removal of colorectal polyps by endoscopic mucosal resection (EMR) and endoscopic mucosal dissection (ESD) in patients with inflammatory bowel disease (IBD). Patients and methods We performed a retrospective review of patients with colonic IBD and colonic polyps >10mm who underwent EMR and/or ESD at our institution between January 1, 2012 and June 31, 2016. Results Ninety-seven patients with pathology-confirmed IBD (median disease duration 16 years) were included. Mild or moderate active colitis (in background biopsies) was seen in 85 %. Of the total 124 polyps, location was ascending colon in 44 %, transverse in 15 % and sigmoid in 18.5 %; of the total, 55 % were < 20 mm and 45 % were ≥20mm in maximal diameter. Using the Paris classification, 56 % of polyps were polypoid sessile (Is) polyps, while 38 % were non-polypoid (IIa, IIb, IIc). EMR was used in 118 polyps, three required ESD, and three by combined EMR-ESD. Seventy-two percent were resected en-bloc; 28 % underwent piecemeal resection. Histology included low-grade dysplasia in 75, serrated adenoma in 31, and tubular adenoma in 14 polyps. Chromoendoscopy was used in 33 (26.6 %). Adverse events occurred in three patients. Colectomy was performed in 11 patients within 12 months. Recurrence was seen in 20 polyps, 11 of which were successfully resected en-bloc using EMR. Polyps ≥ 20 mm and polyps treated with APC were found to have a statistically significantly higher risk of recurrence. Conclusion This study demonstrates the efficacy and safety of endoscopic resection of large polyps in patients with IBD, making them effective alternatives to colectomy.
Complete Surgical Metastasectomy of Renal Cell Carcinoma in the Post-Cytokine Era
Lyon, Timothy D. , Thompson, R. Houston, Shah, Paras , Lohse, Christine M. , Boorjian, Stephen A. , Costello, Brian A. , Cheville, John C. , Leibovich, Bradley C. , Lyon, Timothy D

Mayo Clinic

Journal of Urology | August 8, 2019 | Volume: 203 | Issue: 2 | Pages: 275-282

10.1097/ju.0000000000000488 | PMID 31393812 Get It

The Clinical Use of Cricoid Pressure: First, Do No Harm
Rice, Mark J., Brull, Sorin J. , Zdravković, Marko , Brull, Sorin J

Mayo Clinic

Anesthesia & Analgesia | August 8, 2019 | Volume: 132 | Issue: 1 | Pages: 261-267

10.1213/ane.0000000000004360 | PMID 31397697 Get It

Application of cricoid pressure (CP) during rapid sequence induction and intubation sequence has been a “standard” of care for many decades, despite limited scientific proof of its efficacy in preventing pulmonary aspiration of gastric contents. While some of the current rapid sequence induction and intubation guidelines recommend its use, other international guidelines do not, and many clinicians argue that there is insufficient evidence to either continue or abandon its use. Recently published articles and accompanying editorials have reignited the debate on the efficacy and safety of CP application and have generated multiple responses that pointed out the various (and significant) limitations of the available evidence. Thus, a critical discussion of available data must be undertaken before making a final clinical decision on such an important patient safety issue. In this review, the authors will take an objective look at the available scientific evidence about the effectiveness and safety of CP in patients at risk of pulmonary aspiration of gastric contents. We suggest that current data are inadequate to impose clinical guidelines on the use of CP because we acknowledge that currently there is not, and there may never be, a method to prevent aspiration in all patients. In addition, we reiterate that a universally accepted medical-legal standard for approaching the high-risk aspiration patient does not exist, discuss the differences in practice between the US and international practitioners regarding use of CP, and propose 5 recommendations on how future studies might be designed to obtain optimal scientific evidence about the effectiveness and safety of CP in patients at risk for pulmonary aspiration.
ALG9 Mutation Carriers Develop Kidney and Liver Cysts
Besse, Whitney , Chang, Alex R. , Luo, Jonathan Z. , Triffo, William , Moore, Bryn S. , Gulati, Ashima , Hartzel, Dustin N. , Mane, Shrikant , Torres, Vicente E. , Somlo, Stefan , Torres, Vicente E , Chang, Alexander R , Mirshahi, Tooraj

Mayo Clinic

Journal of the American Society of Nephrology | August 8, 2019 | Volume: 30 | Issue: 11 | Pages: 2091-2102

10.1681/asn.2019030298 | PMID 31395617 Get It

Significance Statement Dominantly inherited polycystic kidney and liver phenotypes occur when epithelial cells in these organs have reduction of polycystin-1 functional dosage. In a cohort of genetically unresolved polycystic liver and kidney disease, the authors identified heterozygous loss of function mutations in ALG9 . ALG9 encodes an endoplasmic reticulum enzyme that builds N -glycans, and the authors show that Alg9 inactivation results in impaired polycystin-1 maturation. Using a novel ‘genotype-first’ approach to ascertain individuals based strictly on their ALG9 genotype from a large cohort of exome-sequenced individuals, the authors find that 7/8 (88%) of ALG9 mutation carriers over age 50 have multiple kidney cysts. Together, these findings identify ALG9 as a novel human polycystic kidney and liver disease gene and support the utility of a genotype-driven approach to candidate disease gene validation and genotype-phenotype correlation. Background Mutations in PKD1 or PKD2 cause typical autosomal dominant polycystic kidney disease (ADPKD), the most common monogenic kidney disease. Dominantly inherited polycystic kidney and liver diseases on the ADPKD spectrum are also caused by mutations in at least six other genes required for protein biogenesis in the endoplasmic reticulum, the loss of which results in defective production of the PKD1 gene product, the membrane protein polycystin-1 (PC1). Methods We used whole-exome sequencing in a cohort of 122 patients with genetically unresolved clinical diagnosis of ADPKD or polycystic liver disease to identify a candidate gene, ALG9 , and in vitro cell-based assays of PC1 protein maturation to functionally validate it. For further validation, we identified carriers of ALG9 loss-of-function mutations and noncarrier matched controls in a large exome-sequenced population-based cohort and evaluated the occurrence of polycystic phenotypes in both groups. Results Two patients in the clinically defined cohort had rare loss-of-function variants in ALG9 , which encodes a protein required for addition of specific mannose molecules to the assembling N-glycan precursors in the endoplasmic reticulum lumen. In vitro assays showed that inactivation of Alg9 results in impaired maturation and defective glycosylation of PC1. Seven of the eight (88%) cases selected from the population-based cohort based on ALG9 mutation carrier state who had abdominal imaging after age 50; seven (88%) had at least four kidney cysts, compared with none in matched controls without ALG9 mutations. Conclusions ALG9 is a novel disease gene in the genetically heterogeneous ADPKD spectrum. This study supports the utility of phenotype characterization in genetically-defined cohorts to validate novel disease genes, and provide much-needed genotype-phenotype correlations.
Noninvasive Assessment of Aortic Pulse Wave Velocity by the Brachial Occlusion-Cuff Technique: Comparative Study
Fabián, Vratislav , Matera, Lukáš , Bayerová, Kristýna , Havlík, Jan , Křemen, Václav , Pudil, Jan , Sajgalik, Pavol , Kremen, Vaclav , Zemánek, David

Mayo Clinic

Sensors | August 8, 2019 | Volume: 19 | Issue: 16 | Pages: 3467

10.3390/s19163467 | PMID 31398931 Get It

Cardiovascular diseases are one of most frequent cause of morbidity and mortality in the world. There is an emerging need for integrated, non-invasive, and easy-to-use clinical tools to assess accurately cardiovascular system primarily in the preventative medicine. We present a novel design for a non-invasive pulse wave velocity (PWV) assessment method integrated in a single brachial blood pressure monitor allowing for up to 100 times more sensitive recording of the pressure pulsations based on a brachial occlusion-cuff (suprasystolic) principle. The monitor prototype with built-in proprietary method was validated with a gold standard reference technique SphygmoCor VX device. The blood pressure and PWV were assessed on twenty-five healthy individuals (9 women, age (37 ± 13) years) in a supine position at rest by a brachial cuff blood pressure monitor prototype, and immediately re-tested using a gold standard method. PWV using our BP monitor was (6.67 ± 0.96) m/s compared to PWV determined by SphygmoCor VX (6.15 ± 1.01) m/s. The correlation between methods using a Pearson’s correlation coefficient was r = 0.88 (p < 0.001). The study demonstrates the feasibility of using a single brachial cuff build-in technique for the assessment of the arterial stiffness from a single ambulatory blood pressure assessment.